Position in EXEL
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$232,113
New position
Shares Held
4,266
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#40
of 70 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 91.86591654946086.ToString("F0")%
Shared 0.ToString("F0")%
None 8.134083450539146.ToString("F0")%
Position in Biotechnology
Healthcare · as of Jun 30, 2026180 WEALTH ADVISORS, LLC holds $26,828,326 across 11 Biotechnology names. EXEL ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MNKD |
Mannkind Corp
|
4,959,351 | $21,126,835 | |
| 2 | MRNA |
Moderna, Inc.
|
35,750 | $2,503,572 | |
| 3 | INCY |
Incyte Corp
|
7,045 | $798,621 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
190,562 | $699,362 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
7,257 | $395,796 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
8,753 | $341,454 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
548 | $272,208 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
4,266 | $232,113 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $232,113 | 4,266 | Shares | Sole | 2026-07-07 | |
| No filing history on record for this holder in this stock. | ||||||